A belimumab injection (Benlysta) is prescribed with other medications as treatment to patients of systemic lupus erythematosus. This type of medication is known as a monoclonal antibody ... Continue Reading →

New Trial Testing Benlysta as Injectable

The Lupus Research Institute is pleased to alert people with lupus of a new Phase III trial testing the efficacy, safety and tolerability of the recently approved Benlysta(r) ... Continue Reading →

Benlysta Continues to Gain Increased Market Share among U.S. Rheumatologists Six-Months Post-Launch

More rheumatologists are prescribing Benlysta for lupus The LaunchTrends(R): Benlysta Wave 3 report, which measures product uptake and commercial effectiveness at six months post ... Continue Reading →

New Lupus Drug Benlysta Approved

The FDA has approved Benlysta, the first new lupus drug since 1955. Benlysta reduces lupus activity; it’s hoped the drug will help patients reduce their need for steroids. Continue Reading →

New Lupus Treatment Benlysta: FAQ

The FDA has approved Benlysta, the first new drug for lupus in 50 years. What is it? Which patients will benefit? Which won’t? Is it safe? WebMD’s FAQ. Continue Reading →

Glaxo’s Revolutionary Lupus Treatment Benlysta Now EU Approved

The first treatment developed for lupus in over 50 years has finally been approved by the European Union this week. The watchdog, European Medicines Agency, has backed the injectable ... Continue Reading →